Kolexia
Corbinais Stephane Gastro-entérologie
Corbinais Stephane
Gastro-entérologie
Centre François-Baclesse
Caen, France
33 Activités
10 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs de l'oesophage Instabilité des microsatellites Tumeurs de l'estomac Adénocarcinome Tumeurs du pancréas Entérite Tumeurs de l'anus Tumeurs épidermoïdes

Collaborateurs

Voir plus
Parzy Aurelie
Parzy Aurelie
Centre François-Baclesse, Caen, France
Galais Marie-Pierre
Galais Marie-Pierre
Centre François-Baclesse, Caen, France
Dos Santos Melanie
Dos Santos Melanie
Hôpital Côte de Nacre, Caen, France
Lefebvre Anne-Charlotte
Lefebvre Anne-Charlotte
Cabinet libéral, Caen, France

Industries

Voir plus
Servier
8 collaboration(s)
Dernière en 2023
Norgine
2 collaboration(s)
Dernière en 2022
Leo Pharma
1 collaboration(s)
Dernière en 2022
Merck-Serono
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
JAMA oncology   19 octobre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
GASPAR: Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT): A Phase II Study (GASPAR)
Essai Clinique (Centre François-Baclesse)   22 décembre 2022
LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
SAMCO: Multicenter Randomized Phase II Study Comparing the Effectiveness and Tolerance of Avelumab Versus Standard 2nd Line Treatment Chemotherapy in Patients With Colorectal Metastatic Cancer With Microsatellite Instability (MSI)
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   18 août 2022
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
BMC cancer   12 mai 2022
A supportive care dedicated hospitalization ward in comprehensive cancer center.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   27 mars 2020
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.
International journal of colorectal disease   18 décembre 2019
E-DIS2: Phase II Randomized Study Measuring the Interest of Pursuing or Not the CT for Non-progressive Patients With Metastatic Esophageal Squamous-cell Cancer After 6 Weeks of LV5FU2-paclitaxel Given After a 1st Line Fluoropyrimidine/Pt Salt CT
Essai Clinique (Centre Oscar-Lambret)   07 août 2018